Proton irradiation suppresses angiogenic genes and impairs cell invasion and tumor growth

Radiation Research

Volumn 178, Issue 1, 2012, Pages 33-45

  Girdhani, Swati ^a   Lamont, Clare ^a   Hahnfeldt, Philip ^a   Abdollahi, Amir ^a   Hlatky, Lynn ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 8; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTON RADIATION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864469299     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2724.1     Document Type: Article

References (52)

1. Suit HD, Goitein M, Munzenrider J, et al. Increased efficacy of radiation therapy by use of proton beam. Strahlenther Onkol 1990; 166:40-4.
2. Fokas E, Kraft G, An H, Engenhart-Cabillic R. Ion beam radiobiology and cancer: time to update ourselves. Biochim Biophys Acta 2009; 1796:216-29.
3. Suit H, Urie M. Proton beams in radiation therapy. J Natl Cancer Inst 1992; 84:155-64.
4. Suit HD. Protons to replace photons in external beam radiation therapy? Clin Oncol (R Coll Radiol) 2003; 15:S29-31.
5. Durante M, Loeffler JS. Charged particles in radiation oncology. Nat Rev Clin Oncol 2010; 7:37-43.
6. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002; 53:407-21.
7. Green LM, Murray DK, Bant AM, et al. Response of thyroid follicular cells to gamma irradiation compared to proton irradiation. I. Initial characterization of DNA damage, micronucleus formation, apoptosis, cell survival, and cell cycle phase redistribution. Radiat Res 2001; 155:32-42.
8. Finnberg N, Wambi C, Ware JH, Kennedy AR, El-Deiry WS. Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo. Cancer Biol Ther 2008; 7:2023-33.
9. Leloup C, Garty G, Assaf G, et al. Evaluation of lesion clustering in irradiated plasmid DNA. Int J Radiat Biol 2005; 81:41-54.
10. Hada M, Sutherland BM. Spectrum of complex DNA damages depends on the incident radiation. Radiat Res 2006; 165:223-30.
11. Goetz W, Morgan MN, Baulch JE. The effect of radiation quality on genomic DNA methylation profiles in irradiated human cell lines. Radiat Res 2010; 175:575-87.
12. Ogata T, Teshima T, Kagawa K, et al. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res 2005; 65:113-20.
13. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
14. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74.
15. Erickson AC, Barcellos-Hoff MH. The not-so innocent bystander: the microenvironment as a therapeutic target in cancer. Expert Opin Ther Targets 2003; 7:71-88.
16. Sachs RK, Shuryak I, Brenner D, Fakir H, Hlatky L, Hahnfeldt P. Second cancers after fractionated radiotherapy: stochastic population dynamics effects. J Theor Biol 2007; 249:518-31.
17. Shuryak I, Hahnfeldt P, Hlatky L, Sachs RK, Brenner DJ. A new view of radiation-induced cancer: integrating short-and long-term processes. Part II: second cancer risk estimation. Radiat Environ Biophys 2009; 48:275-86.
18. Newhauser WD, Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer 2011; 11:438-48.
19. Durante M, Cucinotta FA. Heavy ion carcinogenesis and human space exploration. Nat Rev Cancer 2008; 8:465-72.
20. Jakel O. The relative biological effectiveness of proton and ion beams. Z Med Phys 2008; 18:276-85.
21. Abdollahi A, Schwager C, Kleeff J, et al. Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci USA 2007; 104:12890-5.
22. Bedke J, Kiss E, Behnes CL, et al. Anti-inflammatory effects of alpha integrin antagonism in acute kidney allograft rejection. Am J Pathol 2007; 171:1127-39.
23. Mastyugin V, McWhinnie E, Labow M, Buxton F. A quantitative high-throughput endothelial cell migration assay. J Biomol Screen 2004; 9:712-8.
24. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004; 23:1599-607.
25. Levin KP, Kooy H, Loeffler JS, Delaney TF. Proton beam therapy. Br J Cancer 2005; 93(8):849-54.
26. Takahashi Y, Teshima T, Kawaguchi N, et al. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res 2003; 63:4253-7.
27. Akino Y, Teshima T, Kihara A, et al. Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-smallcell lung cancer cells. Int J Radiat Oncol Biol Phys 2009; 75:475-81.
28. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001; 280:C1358-66.
29. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407:242-8.
30. Hlatky L, Hahnfeldt P, Tsionou C, Coleman CN. Vascular endothelial growth factor: environmental controls and effects in angiogenesis. Br J Cancer Suppl 1996; 27:S151-6.
31. Helmlinger G, Endo M, Ferrara N, Hlatky L, Jain RK. Formation of endothelial cell networks. Nature 2000; 405:139-41.
32. Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metast Rev 1993; 12:303-24.
33. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146:1029-39.
34. Dvorak HF, Nagy JA, Berse B, et al. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci 1992; 667:101-11.
35. Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002; 62:7203-6.
36. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bonemarrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7:1194-201.
37. Bar-Eli M. Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 1999; 67:12-8.
38. Gaugler MH, Neunlist M, Bonnaud S, Aubert P, Benderitter M, Paris F. Intestinal epithelial cell dysfunction is mediated by an endothelial-specific radiation-induced bystander effect. Radiat Res 2007; 167:185-93.
39. Gridley DS, Bonnet RB, Bush DA, et al. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-smallcell lung cancer. Int J Radiat Oncol Biol Phys 2004; 60:759-66.
40. Boyd SR, Gittos A, Richter M, Hungerford JL, Errington RD, Cree IA. Proton beam therapy and iris neovascularisation in uveal melanoma. Eye 2006; 20:832-6.
41. Jang GH, Ha JH, Huh TL, Lee YM. Effect of proton beam on blood vessel formation in early developing zebrafish (Danio rerio) embryos. Arch Pharm Res 2008; 31:779-85.
42. Grabham P, Hu B, Sharma P, Geard C. Effects of ionizing radiation on three-dimensional human vessel models: differential effects according to radiation quality and cellular development. Radiat Res 2011; 175:21-8.
43. Tian J, Pecaut MJ, Coutrakon GB, Slater JM, Gridley DS. Response of extracellular matrix regulators in mouse lung after exposure to photons, protons and simulated solar particle event protons. Radiat Res 2009; 172:30-41.
44. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 2001; 61:2744-50.
45. Qian LW, Mizumoto K, Urashima T, et al. Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 2002; 8:1223-7.
46. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 2001; 61:2207-11.
47. Geng L, Donnelly E, McMahon G, et al. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 2001; 61:2413-9.
48. Hlatky L, Tsionou C, Hahnfeldt P, Coleman CN. Mammary fibroblasts may influence breast tumor angiogenesis via hypoxiainduced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 1994; 54:6083-6.
49. Sofia Vala I, Martins LR, Imaizumi N, et al. Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS One; 5:e11222.
50. Solberg TD, Nearman J, Mullins J, Li S, Baranowska-Kortylewicz J. Correlation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72:918-26.
51. Schneider U, Lomax A, Timmermann B. Second cancers in children treated with modern radiotherapy techniques. Radiother Oncol 2008; 89:135-40.
52. CS Chung NK, Yock T, Tarbell N. Comparative analysis of second malignancy risk in patients treated with proton therapy versus conventional photon therapy. Int J Radiat Oncol Biol Phys 2008; 72:S8.